Abstract:1229 Malignant solid tumors with insufficient blood supply contain a large portion of hypoxic cells that exhibit a high degree of resistance to radiation and chemotherapy partly due to increase of hypoxia inducible factor-1 (HIF-1) and expression of other cellular survival molecules. The residual hypoxic cancer cells surviving radiotherapy/chemotherapy eventually proliferate and lead to cancer relapse. Because cancer cells in hypoxic environment largely depend on glycolysis to generate ATP due to lack of oxygen for the mitochondrial ATP synthesis through oxidative phosphorylation, we tested the hypothesis that inhibition of glycolysis may severely deplete energy supply in hypoxic cancer cells, rendering them unable to repair DNA damage caused by radiation. Using human colon cancer HCT116 cells, we demonstrated that under hypoxic conditions the cancer cells were significantly less sensitive to ionizing radiation (IR) that under normoxic conditions. Inhibition of glycolysis effectively depleted cellular ATP, and preferentially killed cancer cells under hypoxic conditions. Importantly, combination of IR with glycolytic inhibition exhibited synergistic activity against the hypoxic cancer cells, as demonstrated by colony formation assay. Fluorescent microscopic analysis demonstrated that inhibition of glycolysis suppressed the foci formation of the H2AX protein complex, suggesting that ATP depletion disabled the cellular ability to repair IR-induced DNA strand breaks. Furthermore, glycolytic inhibition led to a decrease in protein synthesis and significantly suppressed HIF-1α accumulation under hypoxia, likely further compromising the cell survival pathway. Our findings suggest that inhibition of glycolysis is an effective strategy to effectively kill hypoxic cancer cells, and its combination with radiotherapy is synergistic and may have significant clinical applications in cancer treatment.

Hypoxia stabilizes microtubule networks and decreases tumor cell chemosensitivity to anticancer drugs through Egr-1.

Egr-1 Promotes Hypoxia-Induced Autophagy to Enhance Chemo-Resistance of Hepatocellular Carcinoma Cells.

Overcome radiation resistance in hypoxic cancer cells by inhibition of glycolysis

Tumor hypoxia promotes MAPK signaling by inhibiting prolyl hydroxylation of SOS1

Role of hypoxia in cancer therapy by regulating the tumor microenvironment

The role of hypoxic microenvironment in the progress of tumor

Hypoxia Boosts Aerobic Glycolysis in Carcinoma: A Complex Process for Tumour Development

Hypoxia Promotes Etoposide (VP-16) Resistance in Neuroblastoma CHP126 Cells.

Hypoxia-induced NAD+ Interventions Promote Tumor Survival and Metastasis by Regulating Mitochondrial Dynamics.

Autophagy in hypoxia protects cancer cells against apoptosis induced by nutrient deprivation through a Beclin1-dependent way in hepatocellular carcinoma.

Epigenetic crosstalk between hypoxia and tumor driven by HIF regulation

Hypoxia Promotes Migration/invasion and Glycolysis in Head and Neck Squamous Cell Carcinoma Via an HIF-1α-MTDH Loop.

Hypoxia Alters the Response to Anti-EGFR Therapy by Regulating EGFR Expression and Downstream Signaling in a DNA Methylation-Specific and HIF-Dependent Manner

Hypoxia Promotes Breast Cancer Cell Growth by Activating a Glycogen Metabolic Program

Hypoxia-regulated gene network in drug resistance and cancer progression

Hypoxia-Induced Autophagy Contributes To The Chemoresistance Of Hepatocellular Carcinoma Cells

Role of hypoxia in the tumor microenvironment and targeted therapy

Tumor hypoxia: From basic knowledge to therapeutic implications

Hypoxia-activated nanomedicines for effective cancer therapy

Activation Of Pi3 Kinase/Akt/Hif-1 Alpha Pathway Contributes To Hypoxia-Induced Epithelial-Mesenchymal Transition And Chemoresistance In Hepatocellular Carcinoma

Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance